The Duckhorn Portfolio Announces Fourth Quarter and Fiscal Year 2021 Financial Results
The Duckhorn Portfolio reported a strong fourth quarter with net sales of $70.9 million, up 35.7% year-over-year. Net income increased to $7.4 million, with adjusted net income at $9.2 million. Gross profit reached $34.4 million, a 32.7% rise versus the prior year. Adjusted EBITDA stood at $18.4 million, reflecting a 3.4% increase. For fiscal year 2022, guidance presents expected adjusted EPS between $0.54 and $0.57, amid increased share count and public company costs.
- Net sales increased by 35.7% to $70.9 million in Q4.
- Net income improved to $7.4 million from a loss in the prior year.
- Adjusted EBITDA rose to $18.4 million, a 3.4% increase.
- Gross profit margin decreased by 110 basis points.
- Increased selling, general, and administrative expenses by 50.6%.
Fourth Quarter Net Sales Increase
Fourth Quarter Net Income of
Fourth Quarter Adjusted EBITDA of
Introduces Fiscal Year 2022 Guidance
Fourth Quarter Highlights
-
Net sales were
, an increase of$70.9 million , or$18.7 million 35.7% , versus the prior year period. -
Gross profit was
, an increase of$34.4 million , or$8.5 million 32.7% , versus the prior year period. Adjusted gross profit was , an increase of$34.7 million , or$8.2 million 30.9% , versus the prior year period. -
Net income was
, or$7.4 million per diluted share, versus$0.06 , or$(2.7) million per diluted share, in the prior year period; adjusted net income was$(0.03) , or$9.2 million per diluted share, versus$0.08 , or$7.4 million per diluted share, in the prior year period.$0.07 -
Adjusted EBITDA was
, an increase of$18.4 million , or$0.6 million 3.4% , versus the prior year period, which includes public company costs in the most recent quarter that did not exist in the prior year period. Adjusted EBITDA increased , or$2.3 million 14.3% , versus the prior year when comparing Adjusted EBITDA in the fourth quarter against the prior year period when proportionately burdened by public company costs. -
Cash and cash equivalents were
as of$4.2 million July 31, 2021 , with a leverage ratio of 2.1x net debt (net of deferred financing costs) to trailing twelve months adjusted EBITDA.
Fiscal Year 2021 Highlights
-
Net sales were
, an increase of$336.6 million , or$66.0 million 24.4% , versus the prior year. -
Gross profit was
, an increase of$167.3 million , or$30.5 million 22.3% , versus the prior year. Adjusted gross profit was , an increase of$169.6 million , or$22.2 million 15.1% , versus the prior year. -
Net income was
, or$56.0 million per diluted share, versus$0.52 , or$32.4 million per diluted share, in the prior year period. Adjusted net income was$0.32 , or$62.4 million per diluted share, versus$0.58 , or$49.0 million per diluted share, in the prior year.$0.48 -
Adjusted EBITDA was
, an increase of$117.2 million , or$12.1 million 11.5% , versus the prior year, which includes public company costs in the most recent year that did not exist in the prior year. Adjusted EBITDA increased , or$14.6 million 14.2% , in the fiscal year 2021 versus the prior year when comparing Adjusted EBITDA against the prior year period when proportionately burdened by public company costs.
“I am very pleased to report that we have exceeded our expectations, with a strong fourth quarter that caps off an exceptional year for Duckhorn,” commented
Fourth Quarter 2021 Results
|
Three months ended |
|
Fiscal year ended |
||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||
Net sales growth |
35.7 |
% |
|
9.9 |
% |
|
24.4 |
% |
|
12.2 |
% |
Volume contribution |
40.4 |
% |
|
14.6 |
% |
|
32.4 |
% |
|
19.9 |
% |
Price / mix contribution |
(4.6) |
% |
|
(4.7) |
% |
|
(8.0) |
% |
|
(7.7) |
% |
|
Three months ended |
|
Fiscal year ended |
||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||
Wholesale – Distributors |
68.9 |
% |
|
62.6 |
% |
|
65.3 |
% |
|
60.0 |
% |
Wholesale - |
18.5 |
% |
|
22.0 |
% |
|
16.9 |
% |
|
18.9 |
% |
DTC |
12.6 |
% |
|
15.4 |
% |
|
17.8 |
% |
|
21.1 |
% |
100.0 |
% |
100.0 |
% |
100.0 |
% |
100.0 |
% |
||||
Note: Sum of the individual amounts may not add due to rounding.
Net sales were
Gross profit was
Total selling, general and administrative expenses were
Net income was
Adjusted EBITDA was
Fiscal Year 2022 Guidance
Ryan continued, “As we enter our first full fiscal year as a public company, we are introducing initial guidance that we view as thoughtful and well-calibrated for the currently fluid operating environment. We remain confident in our ability to continue to well-outperform the market, and we look forward to continuing to build upon our legacy as the standard for American fine wine and long-term value creation for all stakeholders.”
In fiscal 2022, we expect to deliver adjusted EPS between
Accordingly, the Company views it as useful to consider these factors in evaluating our operating performance year-over-year. On a like-for-like basis, the guidance range provided for fiscal 2022 adjusted EPS of
The following table provides the Company's guidance range for fiscal year 2022:
(millions, except per share data and percentages) |
Fiscal year ended |
|
|||
Net sales |
|
|
|
|
|
Adjusted EBITDA |
|
|
|
|
|
Adjusted EPS |
|
|
|
|
|
Diluted share count |
114.5 |
|
|
116.5 |
|
Effective tax rate |
|
|
|
|
|
Conference Call and Webcast
The Company will host a conference call to discuss these results at
There will also be a simultaneous, live webcast available on the Company’s investor relations website at https://ir.duckhorn.com. The webcast will be archived for 30 days.
About
Use of Non-GAAP Financial Information
In addition to the Company’s results which are determined in accordance with generally accepted accounting principles in
Forward-Looking Statements
This press release includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “forecast,” “goal,” “project,” and other words of similar meaning. These forward-looking statements address various matters including statements regarding the timing or nature of future operating or financial performance or other events. Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the Company’s ability to manage the growth of its business; the Company’s reliance on its brand name, reputation and product quality; the effectiveness of the Company’s marketing and advertising programs; general competitive conditions, including actions the Company’s competitors may take to grow their businesses; overall decline in the health of the economy and consumer discretionary spending; the occurrence of severe weather events (including fires, floods and earthquakes), catastrophic health events, natural or man-made disasters, social and political conditions or civil unrest; risks associated with disruptions in the Company’s supply chain for grapes and raw and processed materials, including corks, glass bottles, barrels, winemaking additives and agents, water and other supplies; the impact of COVID-19 on the Company’s customers, suppliers, business operations and financial results; disrupted or delayed service by the distributors and government agencies the Company relies on for the distribution of its wines outside of
CONSOLIDATED BALANCE SHEETS (Unaudited, amounts in thousands, except shares and per share data) |
|||||||
|
|
|
|
||||
ASSETS |
|
|
|
||||
Current assets |
|
|
|
||||
Cash |
$ |
4,244 |
|
|
$ |
6,252 |
|
Accounts receivable trade, net |
33,253 |
|
|
26,464 |
|
||
Inventories |
267,737 |
|
|
245,311 |
|
||
Prepaid expenses and other current assets |
9,167 |
|
|
2,686 |
|
||
Total current assets |
314,401 |
|
|
280,713 |
|
||
Long-term assets |
|
|
|
||||
Property and equipment, net |
240,939 |
|
|
242,751 |
|
||
Intangible assets, net |
200,547 |
|
|
208,230 |
|
||
|
425,209 |
|
|
425,209 |
|
||
Other long-term assets |
2,021 |
|
|
1,688 |
|
||
Total long-term assets |
868,716 |
|
|
877,878 |
|
||
Total assets |
$ |
1,183,117 |
|
|
$ |
1,158,591 |
|
|
|
|
|
||||
LIABILITIES AND EQUITY |
|||||||
Current liabilities |
|
|
|
||||
Accounts payable |
$ |
3,556 |
|
|
$ |
3,733 |
|
Accrued expenses |
21,557 |
|
|
15,511 |
|
||
Accrued compensation |
16,845 |
|
|
8,674 |
|
||
Deferred revenue |
3,102 |
|
|
4,148 |
|
||
Derivative instrument |
— |
|
|
5,376 |
|
||
Current maturities of long-term debt |
11,324 |
|
|
13,430 |
|
||
Other current liabilities |
397 |
|
|
935 |
|
||
Total current liabilities |
56,781 |
|
|
51,807 |
|
||
Long-term liabilities |
|
|
|
||||
Revolving line of credit, net |
121,348 |
|
|
239,674 |
|
||
Long-term debt, net of current maturities and debt issuance costs |
114,625 |
|
|
125,844 |
|
||
Deferred income taxes |
86,667 |
|
|
84,638 |
|
||
Other long-term liabilities |
1,458 |
|
|
2,024 |
|
||
Total long-term liabilities |
324,098 |
|
|
452,180 |
|
||
Total liabilities |
380,879 |
|
|
503,987 |
|
||
Equity |
|
|
|
||||
Common stock, |
1,150 |
|
|
1,017 |
|
||
Additional paid-in capital |
726,903 |
|
|
535,372 |
|
||
Retained earnings |
73,634 |
|
|
117,658 |
|
||
Total |
801,687 |
|
|
654,047 |
|
||
Non-controlling interests |
551 |
|
|
557 |
|
||
Total equity |
802,238 |
|
|
654,604 |
|
||
Total liabilities and equity |
$ |
1,183,117 |
|
|
$ |
1,158,591 |
|
CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited, amounts in thousands, except shares and per share data) |
|||||||||||
Three months ended |
Fiscal years ended |
||||||||||
2021 |
|
2020 |
2021 |
|
2020 |
||||||
Net sales (net of excise taxes of |
$ |
70,893 |
|
$ |
52,231 |
|
$ |
336,613 |
|
$ |
270,648 |
Cost of sales |
|
36,506 |
|
|
26,308 |
|
|
169,265 |
|
|
133,766 |
Gross profit |
|
34,387 |
|
|
25,923 |
|
|
167,348 |
|
|
136,882 |
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative expenses |
|
24,398 |
|
|
16,205 |
|
|
89,816 |
|
|
65,908 |
Impairment loss |
|
- |
|
|
11,830 |
|
|
- |
|
|
11,830 |
Casualty (loss) gain, net |
|
77 |
|
|
- |
|
|
(6,559) |
|
|
(4,047) |
Income from operations |
|
9,912 |
|
|
(2,112) |
|
|
84,091 |
|
|
63,191 |
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
2,671 |
|
|
4,019 |
|
|
13,618 |
|
|
17,924 |
Other (income) expense, net |
|
(1,499) |
|
|
(1,250) |
|
|
(6,505) |
|
|
2,457 |
Total other expenses |
|
1,172 |
|
|
2,769 |
|
|
7,113 |
|
|
20,381 |
Income (loss) before income taxes |
|
8,740 |
|
|
(4,881) |
|
|
76,978 |
|
|
42,810 |
Income tax expense (benefit) |
|
1,314 |
|
|
(2,156) |
|
|
21,008 |
|
|
10,432 |
Net income (loss) |
|
7,426 |
|
|
(2,725) |
|
|
55,970 |
|
|
32,378 |
Less: Net loss (income) attributable to non-controlling interest |
|
2 |
|
|
2 |
|
|
6 |
|
|
(1) |
Net income (loss) attributable to The Duckhorn
|
$ |
7,428 |
|
$ |
|
|
$ |
|
|
$ |
|
|
|
|
|
|
|
|
|||||
Net income (loss) per share of common stock: |
|
|
|
|
|
|
|
||||
Basic |
0.06 |
(0.03) |
|
0.52 |
0.32 |
||||||
Diluted |
0.06 |
|
(0.03) |
|
0.52 |
|
0.32 |
||||
|
|
||||||||||
Weighted average shares of common stock outstanding: |
|
|
|
|
|
|
|
||||
Basic |
115,046,793 |
101,713,460 |
|
106,681,496 |
101,713,460 |
||||||
Diluted |
115,294,078 |
|
101,713,460 |
|
106,934,853 |
|
101,713,460 |
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited, amounts in thousands) |
||||||
Fiscal years ended |
||||||
|
2021 |
|
2020 |
|
||
Cash flows from operating activities |
|
|
|
|
||
Net income |
$ |
55,970 |
|
$ |
32,378 |
|
Adjustments to reconcile net income to net cash from operating activities: |
|
|
|
|
|
|
Deferred income taxes |
|
2,029 |
|
|
(5,001) |
|
Depreciation and amortization |
|
21,343 |
|
|
22,755 |
|
Loss on disposal of assets |
|
7 |
|
|
187 |
|
Change in fair value of derivatives |
|
(5,848) |
|
|
2,340 |
|
Amortization of debt issuance costs |
|
1,623 |
|
|
2,121 |
|
Loss on debt extinguishment |
|
272 |
|
|
- |
|
Impairment loss |
|
- |
|
|
11,830 |
|
Equity-based compensation |
|
10,822 |
|
|
1,154 |
|
Change in operating assets and liabilities: |
|
|
|
|
|
|
Accounts receivable trade, net |
|
(6,789) |
|
|
(3,997) |
|
Inventories |
|
(22,426) |
|
|
(10,658) |
|
Prepaid expenses and other current assets |
|
(6,593) |
|
|
(573) |
|
Other long-term assets |
|
(333) |
|
|
(29) |
|
Accounts payable |
|
(45) |
|
|
1,365 |
|
Accrued expenses |
|
7,627 |
|
|
(1,733) |
|
Accrued compensation |
|
8,171 |
|
|
2,295 |
|
Deferred revenue |
|
(1,045) |
|
|
285 |
|
Other current and long-term liabilities |
|
(513) |
|
|
460 |
|
Net cash provided by operating activities |
|
64,272 |
|
|
55,179 |
|
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
|
Purchases of property and equipment |
|
(13,689) |
|
|
(13,624) |
|
Business acquisition, net of cash acquired |
|
- |
|
|
- |
|
Proceeds from sales of property and equipment |
|
122 |
|
|
89 |
|
Net cash used in investing activities |
|
(13,567) |
|
|
(13,535) |
|
|
|
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
|
|
Dividend to parent |
|
(100,000) |
|
|
- |
|
Proceeds from issuance of common stock pursuant to the initial public offering, net of underwriters' discounts and commissions |
|
187,500 |
|
|
- |
|
Payments of deferred offering costs |
|
(6,658) |
|
|
- |
|
Capital contribution from parent |
|
- |
|
|
- |
|
Payments under line of credit |
|
(263,000) |
|
|
(99,000) |
|
Borrowings under line of credit |
|
143,500 |
|
|
59,500 |
|
Extinguishment of long-term debt |
|
(38,131) |
|
|
- |
|
Issuance of long-term debt |
|
38,131 |
|
|
13,100 |
|
Payments of long-term debt |
|
(13,787) |
|
|
(12,741) |
|
Repayment of capital leases |
|
(8) |
|
|
(16) |
|
Debt issuance costs |
|
(260) |
|
|
- |
|
Net cash used in financing activities |
|
(52,713) |
|
|
(39,157) |
|
Net (decrease) increase in cash |
|
(2,008) |
|
|
2,487 |
|
Cash - Beginning of year |
|
6,252 |
|
|
3,765 |
|
Cash - End of year |
$ |
4,244 |
|
$ |
6,252 |
|
|
|
|
|
|
|
|
Supplemental cash-flow information |
|
|
|
|
|
|
Cash paid during the year for: |
|
|
|
|
|
|
Interest, net of amount capitalized |
$ |
12,620 |
|
$ |
15,594 |
|
Income taxes |
$ |
22,743 |
|
$ |
15,604 |
|
Non-cash investing and financing activities |
|
|
|
|
|
|
Property and equipment additions in accounts payable and accrued expenses |
$ |
1,369 |
|
$ |
3,081 |
|
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
Adjusted gross profit, adjusted net income, adjusted EBITDA and adjusted EPS, collectively referred to as “Non-GAAP Financial Measures,” are commonly used in the Company’s industry and should not be construed as an alternative to net income or earnings per share as indicators of operating performance (as determined in accordance with GAAP). These Non-GAAP Financial Measures may not be comparable to similarly titled measures reported by other companies. The Company has included these Non-GAAP Financial Measures because it believes the measures provide management and investors with additional information to evaluate business performance in comparison to budgets, forecasts and prior year financial results.
Non-GAAP Financial Measures are adjusted to exclude certain items that affect comparability. The adjustments are itemized in the tables below. You are encouraged to evaluate these adjustments and the reason the Company considers them appropriate for supplemental analysis. In evaluating adjustments, you should be aware that in the future the Company may incur expenses that are the same as or similar to some of the adjustments set forth below. The presentation of Non-GAAP Financial Measures should not be construed as an inference that future results will be unaffected by unusual or recurring items.
Adjusted EBITDA
Adjusted EBITDA is a non-GAAP financial measure that the Company calculates as net income before interest, taxes, depreciation and amortization, non-cash equity-based compensation expense, purchase accounting adjustments, casualty losses or gains, impairment losses, changes in the fair value of derivatives and certain other items which are not related to our core operating performance. Adjusted EBITDA is a key performance measure the Company uses in evaluating its operational results. The Company believes adjusted EBITDA is a helpful measure to provide investors an understanding of how management regularly monitors the Company’s core operating performance, as well as how management makes operational and strategic decisions in allocating resources. The Company believes adjusted EBITDA also provides management and investors consistency and comparability with the Company’s past financial performance and facilitates period to period comparisons of operations, as it eliminates the effects of certain variations unrelated to its overall performance.
Adjusted EBITDA has certain limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of the Company’s results as reported under GAAP. Some of these limitations include:
- although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and adjusted EBITDA does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;
- adjusted EBITDA does not reflect changes in, or cash requirements for, the Company’s working capital needs;
- adjusted EBITDA does not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments, on the Company’s debt;
- adjusted EBITDA does not reflect income tax payments that may represent a reduction in cash available to the Company; and
- other companies, including companies in the Company’s industry, may calculate adjusted EBITDA differently, which reduce their usefulness as comparative measures.
Because of these limitations, you should consider adjusted EBITDA alongside other financial performance measures, including net income and the Company’s other GAAP results. In evaluating adjusted EBITDA, you should be aware that in the future the Company may incur expenses that are the same as or similar to some of the adjustments in this presentation. The Company’s presentation of adjusted EBITDA should not be construed as an inference that the Company’s future results will be unaffected by the types of items excluded from the calculation of adjusted EBITDA.
Adjusted Gross Profit
Adjusted Gross Profit is a non-GAAP financial measure that the Company calculates as gross profit excluding the impact of purchase accounting adjustments (including depreciation and amortization related to purchase accounting) and bulk wine losses. We believe Adjusted Gross Profit is a useful measure to us and our investors to assist in evaluating our operating performance because it provides consistency and direct comparability with our past financial performance between fiscal periods, as the metric eliminates the effects of non-cash or other expenses unrelated to our core operating performance that would result in fluctuations in a given metric for reasons unrelated to overall continuing operating performance. Adjusted Gross Profit should not be considered a substitute for gross profit or any other measure of financial performance reported in accordance with GAAP.
Adjusted Net Income
Adjusted Net Income is a non-GAAP financial measure that the Company calculates as net income excluding the impact of non-cash equity-based compensation expense, purchase accounting adjustments, casualty losses or gains, impairment losses, changes in the fair value of derivatives and certain other items unrelated to core operating performance, as well as the estimated income tax impacts of all such adjustments included in this non-GAAP performance measure. We believe Adjusted Net Income assists us and our investors in evaluating our performance period-over-period. In calculating Adjusted Net Income, we also calculate the following non-GAAP financial measures which adjust each GAAP-based financial measure for the relevant portion of each adjustment to reach Adjusted Net Income:
-
Adjusted
Net Sales – calculated as net sales excluding the impact of purchase accounting and bulk wine losses; - Adjusted SG&A – calculated as selling, general, and administrative expenses excluding the impacts of purchase accounting, transaction expenses, equity-based compensation, and COVID-19 costs;
- Adjusted Income Tax – calculated as the tax effect of all adjustments to reach Adjusted Net Income based on the applicable blended statutory tax rate for the period.
Adjusted Net Income should not be considered a substitute for net income or any other measure of financial performance reported in accordance with GAAP.
Adjusted EPS
Adjusted EPS is a non-GAAP financial measure that the Company calculates as Adjusted Net Income divided by diluted share count for the applicable period. We believe Adjusted EPS is useful to us and our investors because it improves comparability of results of operations from period to period. Adjusted EPS should not be considered a substitute for net income per share or any other measure of financial performance reported in accordance with GAAP.
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES (Unaudited, amounts in millions, except shares and per share data) |
|||||||||||||
|
|
|
|
|
|
|
Three months ended |
||||||
|
Net Sales |
|
Gross Profit |
|
SG&A |
|
Adjusted EBITDA |
|
Income Tax |
|
Net Income |
|
Diluted EPS |
GAAP Results |
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
|
|
|
|
2.7 |
|
|
|
|
|
|
Income tax expense |
|
|
|
|
|
|
1.3 |
|
|
|
|
|
|
Depreciation and amortization expense |
|
|
0.1 |
|
(1.9) |
|
4.9 |
|
|
|
|
|
|
EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase accounting adjustments |
|
|
0.2 |
|
|
|
0.2 |
|
0.1 |
|
0.2 |
|
0.00 |
Transaction expenses |
|
|
|
|
(1.7) |
|
1.7 |
|
0.5 |
|
1.2 |
|
0.01 |
Change in fair value of derivatives |
|
|
|
|
|
|
(1.0) |
|
(0.3) |
|
(0.7) |
|
(0.01) |
Equity-based compensation |
|
|
|
|
(1.1) |
|
1.1 |
|
0.0 |
|
1.0 |
|
0.01 |
Wildfire costs |
|
|
|
|
|
|
0.1 |
|
0.0 |
|
0.1 |
|
0.00 |
Non-GAAP Results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
||||||
|
Net Sales |
|
Gross Profit |
|
SG&A |
|
Adjusted
|
|
Income Tax |
|
Net Income |
|
Diluted EPS |
GAAP Results |
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
|
|
|
|
4.0 |
|
|
|
|
|
|
Income tax expense |
|
|
|
|
|
|
(2.2) |
|
|
|
|
|
|
Depreciation and amortization expense |
|
|
0.5 |
|
(1.9) |
|
5.3 |
|
|
|
|
|
|
EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase accounting adjustments |
|
|
0.6 |
|
|
|
0.6 |
|
0.2 |
|
0.5 |
|
0.00 |
Impairment loss |
|
|
|
|
|
|
11.8 |
|
2.9 |
|
8.9 |
|
0.09 |
Change in fair value of derivatives |
|
|
|
|
|
|
(1.1) |
|
(0.3) |
|
(0.8) |
|
(0.01) |
Equity-based compensation |
|
|
|
|
(0.3) |
|
0.3 |
|
0.0 |
|
0.3 |
|
0.00 |
Bulk wine loss, net |
0.1 |
|
(0.5) |
|
|
|
0.5 |
|
0.1 |
|
0.4 |
|
0.00 |
Financial statement uplift costs |
|
|
|
|
(0.1) |
|
0.1 |
|
0.0 |
|
0.1 |
|
0.00 |
COVID-19 costs |
|
|
|
|
(1.1) |
|
1.1 |
|
0.3 |
|
0.8 |
|
0.01 |
Non-GAAP Results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal year ended |
||||||
|
Net Sales |
|
Gross Profit |
|
SG&A |
|
Adjusted
|
|
Income Tax |
|
Net Income |
|
Diluted EPS |
GAAP Results |
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
|
|
|
|
13.6 |
|
|
|
|
|
|
Income tax expense |
|
|
|
|
|
|
21.0 |
|
|
|
|
|
|
Depreciation and amortization expense |
|
|
0.6 |
|
(7.7) |
|
21.3 |
|
|
|
|
|
|
EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase accounting adjustments |
|
|
1.7 |
|
|
|
1.7 |
|
0.5 |
|
1.2 |
|
0.01 |
Transaction expenses |
|
|
|
|
(4.0) |
|
4.0 |
|
1.1 |
|
2.9 |
|
0.03 |
Change in fair value of derivatives |
|
|
|
|
|
|
(5.8) |
|
(1.6) |
|
(4.3) |
|
(0.04) |
Equity-based compensation |
|
|
|
|
(10.6) |
|
10.6 |
|
0.3 |
|
10.3 |
|
0.10 |
Casualty loss (gain), net |
|
|
|
|
|
|
(7.8) |
|
(2.1) |
|
(5.7) |
|
(0.05) |
Loss on debt extinguishment |
|
|
|
|
|
|
0.3 |
|
0.1 |
|
0.2 |
|
0.00 |
Financial statement uplift costs |
|
|
|
|
(0.4) |
|
0.4 |
|
0.1 |
|
0.3 |
|
0.00 |
Wildfire costs |
|
|
|
|
|
|
1.3 |
|
0.3 |
|
0.9 |
|
0.01 |
COVID-19 costs |
|
|
|
|
(0.7) |
|
0.7 |
|
0.2 |
|
0.5 |
|
0.00 |
Non-GAAP Results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal year ended |
||||||
|
Net Sales |
|
Gross Profit |
|
SG&A |
|
Adjusted EBITDA |
|
Income Tax |
|
Net Income |
|
Diluted EPS |
GAAP Results |
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
|
|
|
|
17.9 |
|
|
|
|
|
|
Income tax expense |
|
|
|
|
|
|
10.4 |
|
|
|
|
|
|
Depreciation and amortization expense |
|
|
2.2 |
|
(7.7) |
|
22.8 |
|
|
|
|
|
|
EBITDA |
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase accounting adjustments |
|
|
5.5 |
|
|
|
5.5 |
|
1.3 |
|
4.1 |
|
0.04 |
Transaction expenses |
|
|
|
|
(0.2) |
|
0.2 |
|
0.0 |
|
0.2 |
|
0.00 |
Impairment loss |
|
|
|
|
|
|
11.8 |
|
2.9 |
|
8.9 |
|
0.09 |
Change in fair value of derivatives |
|
|
|
|
|
|
2.3 |
|
0.6 |
|
1.8 |
|
0.02 |
Equity-based compensation |
|
|
|
|
(1.2) |
|
1.2 |
|
0.0 |
|
1.2 |
|
0.01 |
Casualty loss (gain), net |
|
|
|
|
|
|
(4.0) |
|
(1.0) |
|
(3.1) |
|
(0.03) |
Bulk wine loss, net |
(1.1) |
|
2.8 |
|
|
|
2.8 |
|
0.7 |
|
2.1 |
|
0.02 |
Financial statement uplift costs |
|
|
|
|
|
|
0.5 |
|
0.1 |
|
0.4 |
|
0.00 |
COVID-19 costs |
|
|
|
|
(1.4) |
|
1.4 |
|
0.3 |
|
1.0 |
|
0.01 |
Non-GAAP Results |
|
|
|
|
|
|
|
|
|
|
|
|
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20211004005928/en/
Investor Contact
ir@duckhorn.com
707-302-2635
Media Contact
DuckhornPR@icrinc.com
203-682-8200
Source:
FAQ
What are Duckhorn Portfolio's Q4 2021 financial results?
How does Duckhorn's fiscal year 2022 guidance compare to 2021?
What contributed to Duckhorn's revenue growth in Q4 2021?